Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India

Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India


Emcure Pharmaceuticals has announced the price revision of its weight management drug Poviztra (semaglutide injection) across India.

The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses).

The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple administration and precise dosing.

As the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s semaglutide injection for obesity, Emcure aims to expand access and enable more patients to benefit from this proven therapy at the revised price.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 02 2026 | 6:04 PM IST



Source link

Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India

JLR announces wholesale and retail sales for Q4 of FY2026


JLR Q4 wholesale volumes up 61.1% QoQ

JLR today reports its wholesale and retail sales for the fourth quarter of FY26 (three-months to 31 March 2026) and the full year ended 31 March 2026. As anticipated and previously indicated, fourth quarter volumes rose significantly versus the prior quarter, as operations recovered and production returned to normal levels following the cyber incident. Full year volumes were impacted by US tariffs, China market challenges, planned wind down of legacy Jaguar models ahead of new Jaguar launch and production stoppages following the cyber incident.

Wholesale volumes for the fourth quarter were 95,300 units (excluding the Chery Jaguar Land Rover China (‘CJLR’) JV), down 14.5% year-on-year, reflecting ongoing challenges in certain markets and the planned wind down of legacy Jaguar models ahead of new Jaguar launch. Q4 wholesale volumes increased 61.1% compared to Q3 FY26, reflecting a return to normal production levels following the cyber incident. Compared to the prior year, wholesale volumes for the fourth quarter were down in all markets, aside from Europe, which was up 4.1%. Volumes were lower in the UK (-23.1%), North America (-19.0%), China (-29.8%), Overseas (-7.9%) and MENA (-2.4%). Wholesale volumes for FY26 were 307,900* units, down 23.2% versus FY25.

 

The overall mix of Range Rover, Range Rover Sport and Defender models was 77.1% of total wholesale volumes in Q4 FY26, up from 66.3% in Q4 FY25 and up from 74.3% in the prior quarter. For the full year, the mix of the same models was 76.5%, up from 67.8% the previous year.

Retail sales for the fourth quarter of 92,700 units (including CJLR) were down 14.3% year on-year but up 16.2% compared to Q3 FY26. Compared to the prior year, retail volumes for the fourth quarter were down in all markets, with the UK down 2.9%, North America down 13.8%, Europe down 6.4%, China down 34.6%, Overseas down 16.2% and MENA down 29.6%. Retail volumes for FY26 were 352,300 units, down 17.8% versus FY25.

JLR will report its fourth quarter and full year results for the period ended 31 March 2026 in May 2026.



Source link

Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India

Interest rate on GOI Floating Rate Bond 2028 to be 6.17% for next six-months


Reserve Bank of India has announced that the rate of interest on Government of India Floating Rate Bond 2028 (FRB 2028) applicable for the half year April 04, 2026 to October 03, 2026 shall be 6.17 per cent per annum. FRB 2028 carries a coupon, which has a base rate equivalent to the average of the Weighted Average Yield (WAY) of last three auctions (from the rate fixing day i.e., April 04, 2026) of 182 Day T-Bills, plus a fixed spread (0.64 per cent).
 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 02 2026 | 6:04 PM IST



Source link

Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India

Maximum temperatures likely to be normal to below normal over many parts of country in summer season


India Meteorological Department or IMD has stated in a latest update that during the 2026 hot weather season (AprilJune), maximum temperatures are likely to be normal to below normal over many parts of the country except most parts of east and northeast India, as well as eastern parts of central India and adjoining peninsular regions where above-normal maximum temperatures are expected. During the season (AMJ), above-normal minimum temperatures are likely over most parts of the country except some regions of Maharashtra and Telangana where normal to below normal minimum temperatures are likely. During April 2026, monthly maximum temperatures are likely to be normal to below normal over many parts of the country. However, above-normal maximum temperatures are expected over many parts of east and northeast India and some parts of northwest India and southern peninsular India. Above-normal monthly minimum temperatures are most likely over most parts of India, except some isolated pockets over south peninsula where normal minimum temperatures are likely during April 2026.
 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 02 2026 | 6:04 PM IST



Source link

Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India

Emami to acquire balance 73.5% stake in Axiom Ayurveda


Emami has executed a definitive agreement on 1 April 2026, to acquire the remaining ~73.5% stake in Axiom Ayurveda (Axiom) subject to completion of customary closing conditions.

In the first tranche, Emami acquired ~36.7% additional stake (existing stake ~26.5%). While the definitive agreement was executed yesterday, the acquisition is expected to be completed in a phased manner over the next three months, in accordance with the terms of the agreement and applicable regulatory requirements. The transaction, approved by the Board of Directors of Emami, involves an aggregate consideration not exceeding Rs.200 crore.

Axiom’s portfolio includes beverage products under the brand AloFrut, health juices under the brand Axiom Jeevan Ras, and beauty products under the brand Mukti Gold.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 02 2026 | 5:50 PM IST



Source link

Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra in India

LG Electronics India sells 1 million+ air conditioners in Q1 of 2026


LG Electronics India (LGE India) today announced the sale of 1 million+ air conditioners in the first quarter of 2026. This landmark achievement marks the fastest and strongest start to a summer season in the company’s history in India. This milestone not only underscores LGE India’s exceptional execution capabilities and supply chain agility, but also cements its position as the decisive leader in India’s fast-growing and highly competitive air conditioner market.

A key driver of this achievement was LGE India’s first-mover advantage with regards to launching its new BEE star-rated compliant AC line-up well ahead of the season, ensuring that retail partners and consumers could seamlessly transition to superior, energy-efficient products without disruption. Complementing this, LGE India’s marketing campaign during the ICC World Cup also delivered great reach and consumer engagement at scale, driving unprecedented brand salience and purchase intent.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 02 2026 | 5:50 PM IST



Source link

YouTube
Instagram
WhatsApp